Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients
Abstract Background While immune checkpoint blockade has greatly improved clinical outcomes in diseases such as melanoma, there remains a need for predictive biomarkers to determine who will likely benefit most from which therapy. To date, most biomarkers of response have been identified in the tumo...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
2018-03-01
|
| Serie: | Journal for ImmunoTherapy of Cancer |
| Accesso online: | http://link.springer.com/article/10.1186/s40425-018-0328-8 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|